All Cosmos Bio-Tech Holding Corporation

Taiwan Stock Exchange 4148.TW

All Cosmos Bio-Tech Holding Corporation Revenue for the year ending December 31, 2023: USD 92.07 M

All Cosmos Bio-Tech Holding Corporation Revenue is USD 92.07 M for the year ending December 31, 2023, a -23.76% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

All Cosmos Bio-Tech Holding Corporation Revenue for the year ending December 31, 2022 was USD 120.77 M, a 52.36% change year over year.
All Cosmos Bio-Tech Holding Corporation Revenue for the year ending December 31, 2021 was USD 79.27 M, a 35.72% change year over year.
All Cosmos Bio-Tech Holding Corporation Revenue for the year ending December 31, 2020 was USD 58.40 M, a -1.17% change year over year.
All Cosmos Bio-Tech Holding Corporation Revenue for the year ending December 31, 2019 was USD 59.09 M, a -32.76% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Taiwan Stock Exchange: 4148.TW

All Cosmos Bio-Tech Holding Corporation

CEO	Dr. Shih Hao Peng Ph.D.
IPO Date	June 9, 2017
Location	Cayman Islands
Headquarters	190 Elgin Avenue
Employees	368
Sector	Health Care
Industries Biotechnology Fertilizers

Description

All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In addition, the company is involved in the research and forest plantation activities. It also exports its products to Taiwan, Indonesia, Vietnam, and China. All Cosmos Bio-Tech Holding Corporation was founded in 1999 and is headquartered in George Town, the Cayman Islands.

Key trends

Past 5 years